Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 16Neoplasms 4Neoplasm Metastasis 4Prostatic Neoplasms 3Multiple Myeloma 3Giant Cell Tumor of Bone 3Carcinoma, Renal Cell 3Smoldering Multiple Myeloma 2Recurrence 2Osteoporosis 2Melanoma 2Kidney Neoplasms 2Bone Cysts, Aneurysmal 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Cancer Metastatic 1Parathyroid Neoplasms 1Osteoporotic Fractures 1Osteopetrosis, mild autosomal recessive form 1Osteopetrosis, Autosomal Recessive 7 1Osteoblastoma 1Neoplastic Cells, Circulating 1Musculoskeletal Pain 1Mastocytosis, Systemic 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Hyperparathyroidism, Primary 1Granuloma, Giant Cell 1Giant Cell Tumors 1

Interventions

Carboplatin 330Pemetrexed 266Cisplatin 234Docetaxel 195Paclitaxel 182Radiotherapy 181Erlotinib Hydrochloride 153pembrolizumab 147Gemcitabine 147Bevacizumab 125Drug Therapy 121Radiosurgery 115Nivolumab 112osimertinib 92durvalumab 88Gefitinib 67atezolizumab 63Vinorelbine 63Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 54anlotinib 42Immunotherapy 42Taxes 39Blood Specimen Collection 39Ipilimumab 38130-nm albumin-bound paclitaxel 38Specimen Handling 36Immune Checkpoint Inhibitors 35Radiation 34Albumin-Bound Paclitaxel 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Non-Small-Cell Lung × Denosumab × Clear all
NCT03958565 2026-06-03

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

University of Colorado, Denver

Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡